Skip to content

Analysis of the diagnostic and prognostic value of serum IL-6, IL-1ß, and Sestrin2 levels in patients with Acute Ischemic stroke

A Retrospective Study on the Diagnostic and Prognostic Value of Serum Sestrin2 Levels in Acute Ischemic Stroke

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600124185
Enrollment
Unknown
Registered
2026-05-08
Start date
2026-07-01
Completion date
Unknown
Last updated
2026-05-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute ischaemic stroke

Interventions

Control group:None
Acute ischaemic stroke group:None

Sponsors

Xinchang County People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: AIS Group: 1. Confirmed diagnosis of acute ischemic stroke by brain CT or MRI between June 2024 and June 2025; 2. Age >= 18 years 3. Time from symptom onset to admission within 24 hours; 4. Eligible residual serum samples collected at admission are available in the biobank; 5. Complete clinical data and 3-month follow-up data after stroke onset are available in the electronic medical record system; Healthy Control Group: 1. Healthy individuals who underwent health check-ups at the physical examination center of our hospital between June 2024 and June 2025; 2. Aged >= 18 years; 3. Eligible residual serum samples collected at the time of the health check-up are available in the biobank; 4. Complete demographic data are available.

Exclusion criteria

Exclusion criteria: AIS Group: 1. Diagnosis of brain tumor, intracerebral hemorrhage, or mixed stroke; 2. Concurrent autoimmune disease, active infection, malignant tumor, or failure of vital organs (heart, lung, liver, kidney); 3. Use of glucocorticoids, immunosuppressants, or immunomodulators within 30 days prior to admission; 4. Pregnant or breastfeeding women; 5. Missing critical clinical data or lost to follow-up.

Design outcomes

Primary

MeasureTime frame
Modified Rankin Scale (mRS) score;

Secondary

MeasureTime frame
Sestrin2;IL-6;IL-1ß;

Countries

China

Contacts

Public ContactZehua Jin

Xinchang County People's Hospital

17706856910@163.com+86 575 8638 0712

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Aug 23, 2026